CIA BRASILEIRA DE DIS- ADR (CBD) Forecast, Price Target & Analyst Ratings

NYSE:CBD • US20440T3005

Current stock price

0.445 USD
-0.01 (-3.05%)
At close:
0.4357 USD
-0.01 (-2.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CIA BRASILEIRA DE DIS- ADR (CBD).

Forecast Snapshot

Consensus Price Target

Price Target
$1.53
+ 244.19% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 1, 2024
Period
Q1 / 2024
EPS Estimate
-R$0.23
Revenue Estimate
4.983B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
50.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.53
Upside
+ 244.19%
From current price of $0.45 to mean target of $1.53, Based on 16 analyst forecasts
Low
$0.64
Median
$1.00
High
$6.48

Price Target Revisions

1 Month
-19.66%
3 Months
-10.73%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for CBD. The average price target is 1.53 USD. This implies a price increase of 244.19% is expected in the next year compared to the current price of 0.445.
The average price target has been revised downward by 10.73% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CBD Current Analyst RatingCBD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CBD Historical Analyst RatingsCBD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
50.00%
CBD was analyzed by 16 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about CBD.
In the previous month the buy percentage consensus was at a similar level.
CBD was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-05-04B of A SecuritiesUpgrade Underperform -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 1, 2024
Period
Q1 / 2024
EPS Estimate
-R$0.23
Revenue Estimate
4.983B
Revenue Q2Q
10.83%
EPS Q2Q
54.35%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
-0.72%
Revenue (3 Months)
-1.13%
EPS (1 Month)
54.81%
EPS (3 Months)
58.85%

Next Earnings Summary

CBD is expected to report earnings on 5/1/2024. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 4.98B USD.
The next earnings revenue estimate has been revised downward by 1.13% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CBD revenue by date.CBD revenue by date.
16.298B
-68.20%		17.321B
6.28%		19.25B
11.14%		21.612B
12.27%		22.673B
4.91%		24.109B
6.33%		27.966B
16.00%
EBITDA
YoY % growth
CBD ebitda by date.CBD ebitda by date.
2.434B
-54.12%		1.834B
-24.65%		1.233B
-32.77%		1.684B
36.58%		1.877B
11.46%		2.048B
9.11%		2.39B
16.70%
EBIT
YoY % growth
CBD ebit by date.CBD ebit by date.
317M
-88.43%		-68M
-121.45%		97M
242.65%		502.53M
418.07%		678.29M
34.98%		797.06M
17.51%		1.126B
41.27%
Operating Margin
CBD operating margin by date.CBD operating margin by date.
1.95%-0.39%0.50%2.33%2.99%3.31%4.03%
EPS
YoY % growth
CBD eps by date.CBD eps by date.
N/A
-15.54%		-0.35
-117.51%		-4.41
-1,171.43%		-0.72
83.74%		-0.37
48.56%		-0.24
34.25%		N/A

All data in BRL

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.23
54.35%		-0.20
69.79%		-0.16
93.84%		-0.04
93.35%
Revenue
Q2Q % growth		4.983B
10.83%		5.292B
11.29%		5.295B
11.66%		5.88B
11.85%
EBITDA
Q2Q % growth		376.7M
53.13%		405.96M
-23.98%		424.21M
-50.33%		546M
-57.81%
EBIT
Q2Q % growth		66.597M
295.87%		88.825M
386.53%		117.86M
2,846.50%		234.19M
48.22%

All data in BRL

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CBD Yearly Revenue VS EstimatesCBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
CBD Yearly EPS VS EstimatesCBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.83%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.72%
Revenue Next 5 Year
8.97%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
102.85%
EBIT Next 5 Year
76.66%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CIA BRASILEIRA DE DIS- ADR / CBD Forecast FAQ

Can you provide the average price target for CIA BRASILEIRA DE DIS- ADR stock?

16 analysts have analysed CBD and the average price target is 1.53 USD. This implies a price increase of 244.19% is expected in the next year compared to the current price of 0.445.

What is the next earnings date for CBD stock?

CIA BRASILEIRA DE DIS- ADR (CBD) will report earnings on 2024-05-01, after the market close.

What are the consensus estimates for CBD stock next earnings?

The consensus EPS estimate for the next earnings of CIA BRASILEIRA DE DIS- ADR (CBD) is -0.23 USD and the consensus revenue estimate is 4.98B USD.

Can you provide the expected long term growth rate for CIA BRASILEIRA DE DIS- ADR stock?

The expected long term growth rate for CIA BRASILEIRA DE DIS- ADR (CBD) is 6.72%.